Prenatal paraben exposure and atopic dermatitis-related outcomes among children.
allergy
atopic dermatitis
paraben
prenatal
sex
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
01
04
2021
received:
19
11
2020
accepted:
13
04
2021
pubmed:
3
5
2021
medline:
14
10
2021
entrez:
2
5
2021
Statut:
ppublish
Résumé
Parabens, widely used as preservatives in cosmetics, foods, and other consumer products, are suspected of contributing to allergy susceptibility. The detection of parabens in the placenta or amniotic fluid raised concerns about potential health consequences for the child. Recently, an increased asthma risk following prenatal exposure has been reported. Here, we investigated whether prenatal paraben exposure can influence the risk for atopic dermatitis (AD). 261 mother-child pairs of the German mother-child study LINA were included in this analysis. Eight paraben species were quantified in maternal urine obtained at gestational week 34. According to the parental report of physician-diagnosed AD from age 1 to 8 years, disease onset, and persistence, childhood AD was classified into four different phenotypes. 4.6% (n = 12) and 12.3% (n = 32) of the children were classified as having very early-onset AD (until age two) either with or without remission, 11.9% (n = 31) as early-onset (after age two), and 3.1% (n = 8) as childhood-onset AD (after age six). Exposure to ethylparaben and n-butylparaben was associated with an increased risk to develop very early-onset AD without remission (EtP: adj.OR/95% CI:1.44/1.04-2.00,nBuP:adj.OR/95% CI:1.95/1.22-3.12). The effects of both parabens were predominant in children without a history of maternal AD and independent of children's sex. Prenatal EtP or nBuP exposure may increase children's susceptibility for persistent AD with disease onset at very early age. This association was particularly pronounced in children without a history of maternal AD, indicating that children without a genetic predisposition are more susceptible to paraben exposure.
Sections du résumé
BACKGROUND
Parabens, widely used as preservatives in cosmetics, foods, and other consumer products, are suspected of contributing to allergy susceptibility. The detection of parabens in the placenta or amniotic fluid raised concerns about potential health consequences for the child. Recently, an increased asthma risk following prenatal exposure has been reported. Here, we investigated whether prenatal paraben exposure can influence the risk for atopic dermatitis (AD).
METHODS
261 mother-child pairs of the German mother-child study LINA were included in this analysis. Eight paraben species were quantified in maternal urine obtained at gestational week 34. According to the parental report of physician-diagnosed AD from age 1 to 8 years, disease onset, and persistence, childhood AD was classified into four different phenotypes.
RESULTS
4.6% (n = 12) and 12.3% (n = 32) of the children were classified as having very early-onset AD (until age two) either with or without remission, 11.9% (n = 31) as early-onset (after age two), and 3.1% (n = 8) as childhood-onset AD (after age six). Exposure to ethylparaben and n-butylparaben was associated with an increased risk to develop very early-onset AD without remission (EtP: adj.OR/95% CI:1.44/1.04-2.00,nBuP:adj.OR/95% CI:1.95/1.22-3.12). The effects of both parabens were predominant in children without a history of maternal AD and independent of children's sex.
CONCLUSION
Prenatal EtP or nBuP exposure may increase children's susceptibility for persistent AD with disease onset at very early age. This association was particularly pronounced in children without a history of maternal AD, indicating that children without a genetic predisposition are more susceptible to paraben exposure.
Substances chimiques
Parabens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3122-3132Informations de copyright
© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Halla N, Fernandes IP, Heleno SA, et al. Cosmetics preservation: a review on present strategies. Molecules. 2018;23(7):1571.
Soni MG, Carabin IG, Burdock GA. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol. 2005;43(7):985-1015.
Haman C, Dauchy X, Rosin C, Munoz JF. Occurrence, fate and behavior of parabens in aquatic environments: a review. Water Res. 2015;68:1-11.
Bledzka D, Gromadzinska J, Parabens WW. From environmental studies to human health. Environ Int. 2014;67:27-42.
Dewalque L, Pirard C, Charlier C. Measurement of urinary biomarkers of parabens, benzophenone-3, and phthalates in a Belgian population. Biomed Res Int. 2014;2014:649314.
Calafat AM, Ye X, Wong LY, Bishop AM, Needham LL. Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006. Environ Health Perspect. 2010;118(5):679-685.
Frederiksen H, Jensen TK, Jorgensen N, et al. Human urinary excretion of non-persistent environmental chemicals: an overview of Danish data collected between 2006 and 2012. Reproduction. 2014;147(4):555-565.
Artacho-Cordon F, Rios-Arrabal S, Leon J, et al. Adipose tissue concentrations of non-persistent environmental phenols and local redox balance in adults from Southern Spain. Environ Int. 2019;133(Pt A):105118.
Nowak K, Ratajczak-Wrona W, Gorska M, Jablonska E. Parabens and their effects on the endocrine system. Mol Cell Endocrinol. 2018;474:238-251.
Nishihama Y, Yoshinaga J, Iida A, et al. Association between paraben exposure and menstrual cycle in female university students in Japan. Reprod Toxicol. 2016;63:107-113.
Leppert B, Strunz S, Seiwert B, et al. Maternal paraben exposure triggers childhood overweight development. Nat Commun. 2020;11(1):561.
Hu P, Kennedy RC, Chen X, et al. Differential effects on adiposity and serum marker of bone formation by post-weaning exposure to methylparaben and butylparaben. Environ Sci Pollut Res Int. 2016;23(21):21957-21968.
Nowak K, Jablonska E, Ratajczak-Wrona W. Immunomodulatory effects of synthetic endocrine disrupting chemicals on the development and functions of human immune cells. Environ Int. 2019;125:350-364.
Bredin J, Davin-Regli A, Pages JM. Propyl paraben induces potassium efflux in Escherichia coli. J Antimicrob Chemother. 2005;55(6):1013-1015.
Hu J, Raikhel V, Gopalakrishnan K, et al. Effect of postnatal low-dose exposure to environmental chemicals on the gut microbiome in a rodent model. Microbiome. 2016;4(1):26.
Jackson-Browne MS, Henderson N, Patti M, Spanier A, Braun JM. The impact of early-life exposure to antimicrobials on asthma and eczema risk in children. Curr Environ Health Rep. 2019;6(4):214-224.
Savage JH, Matsui EC, Wood RA, Keet CA. Urinary levels of triclosan and parabens are associated with aeroallergen and food sensitization. J Allergy Clin Immunol. 2012;130(2):453.
Spanier AJ, Fausnight T, Camacho TF, Braun JM. The associations of triclosan and paraben exposure with allergen sensitization and wheeze in children. Allergy Asthma Proc. 2014;35(6):475-481.
Quiros-Alcala L, Hansel NN, McCormack MC, Matsui EC. Paraben exposures and asthma-related outcomes among children from the US general population. J Allergy Clin Immunol. 2019;143(3):948.
Mitsui-Iwama M, Yamamoto-Hanada K, Fukutomi Y, et al. Exposure to paraben and triclosan and allergic diseases in Tokyo: a pilot cross-sectional study. Asia Pac Allergy. 2019;9(1). https://doi.org/10.5415/apallergy.2019.9.e5
Kolatorova L, Duskova M, Vitku J, Starka L. Prenatal exposure to bisphenols and parabens and impacts on human physiology. Physiol Res. 2017;66:S305-S315.
Lee-Sarwar K, Hauser R, Calafat AM, et al. Prenatal and early-life triclosan and paraben exposure and allergic outcomes. J Allergy Clin Immunol. 2018;142(1):269.
Vernet C, Pin I, Giorgis-Allemand L, et al. In utero exposure to select phenols and phthalates and respiratory health in five-year-old boys: a prospective study. Environ Health Perspect. 2017;125(9):97006.
Berger K, Eskenazi B, Balmes J, Holland N, Calafat AM, Harley KG. Associations between prenatal maternal urinary concentrations of personal care product chemical biomarkers and childhood respiratory and allergic outcomes in the CHAMACOS study. Environ Int. 2018;121(Pt 1):538-549.
Lowe AJ, Wang X, Mueller JF, et al. Exposure to breast milk triclosan and parabens and eczema phenotypes at 12 months: a nested case-control study. J Allergy Clin Immunol. 2019;144(4):1136.
Bieber T. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine. Allergy. 2012;67(12):1475-1482.
Schlittenbauer L, Seiwert B, Reemtsma T. Ultrasound-assisted hydrolysis of conjugated parabens in human urine and their determination by UPLC-MS/MS and UPLC-HRMS. Anal Bioanal Chem. 2016;408(6):1573-1583.
Bieber T, D'Erme AM, Akdis CA, et al. Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go? J Allergy Clin Immunol. 2017;139(4S):S58-S64.
Wen HJ, Chen PC, Chiang TL, Lin SJ, Chuang YL, Guo YL. Predicting risk for early infantile atopic dermatitis by hereditary and environmental factors. Br J Dermatol. 2009;161(5):1166-1172.
Xu F, Yan S, Zheng Q, et al. Residential risk factors for atopic dermatitis in 3- to 6-year old children: a cross-sectional study in Shanghai, China. Int J Environ Res Public Health. 2016;13(6):537.
Schuttelaar ML, Kerkhof M, Jonkman MF, et al. Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy. 2009;64(12):1758-1765.
Bisgaard H, Halkjaer LB, Hinge R, et al. Risk analysis of early childhood eczema. J Allergy Clin Immunol. 2009;123(6):1355.
Herberth G, Hinz D, Roder S, et al. Maternal immune status in pregnancy is related to offspring's immune responses and atopy risk. Allergy. 2011;66(8):1065-1074.
Bauer T, Trump S, Ishaque N, et al. Environment-induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children. Mol Syst Biol. 2016;12(3):861.
Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113(2):192-200.
Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach, 2nd edn. New York, NY: Guilford Press; 2018.
Althouse AD. Adjust for multiple comparisons? it's not that simple. Ann Thorac Surg. 2016;101(5):1644-1645.
Bonamonte D, Filoni A, Vestita M, Romita P, Foti C, Angelini G. The role of the environmental risk factors in the pathogenesis and clinical outcome of atopic dermatitis. Biomed Res Int. 2019;2019:2450605.
Stiemsma LT, Michels KB. The role of the microbiome in the developmental origins of health and disease. Pediatrics. 2018;141(4). https://doi.org/10.1542/peds.2017-2437
Towers CV, Terry PD, Lewis D, et al. Transplacental passage of antimicrobial paraben preservatives. J Expo Sci Environ Epidemiol. 2015;25(6):604-607.
Frederiksen H, Taxvig C, Hass U, Vinggaard AM, Nellemann C. Higher levels of ethyl paraben and butyl paraben in rat amniotic fluid than in maternal plasma after subcutaneous administration. Toxicol Sci. 2008;106(2):376-383.
Park NY, Cho YH, Choi K, et al. Parabens in breast milk and possible sources of exposure among lactating women in Korea. Environ Pollut. 2019;255(Pt 2):113142.
Rodriguez-Gomez R, Dorival-Garcia N, Zafra-Gomez A, Camino-Sanchez FJ, Ballesteros O, Navalon A. New method for the determination of parabens and bisphenol A in human milk samples using ultrasound-assisted extraction and clean-up with dispersive sorbents prior to UHPLC-MS/MS analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;992:47-55.
Grecco CF, Souza ID, Queiroz MEC. Recent development of chromatographic methods to determine parabens in breast milk samples: a review. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1093-1094:82-90.
Grecco C, Souza I, Acquaro Junior V, Queiroz M. Determination of parabens in breast milk samples by dispersive liquid-liquid microextraction (DLLME) and ultra-high-performance liquid chromatography tandem mass spectrometry. J Braz Chem Soc. 2018;30. https://doi.org/10.21577/0103-5053.20180151
Fisher M, MacPherson S, Braun JM, et al. Paraben concentrations in maternal urine and breast milk and its association with personal care product use. Environ Sci Technol. 2017;51(7):4009-4017.
Ishiwatari S, Suzuki T, Hitomi T, Yoshino T, Matsukuma S, Tsuji T. Effects of methyl paraben on skin keratinocytes. J Appl Toxicol. 2007;27(1):1-9.
Jepsen AA, Chawes BL, Carson CG, et al. High breast milk IL-1beta level is associated with reduced risk of childhood eczema. Clin Exp Allergy. 2016;46(10):1344-1354.
Aung MT, Ferguson KK, Cantonwine DE, et al. Associations between maternal plasma measurements of inflammatory markers and urinary levels of phenols and parabens during pregnancy: a repeated measures study. Sci Total Environ. 2019;650(Pt 1):1131-1140.
Okubo T, Yokoyama Y, Kano K, Kano I. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR. Food Chem Toxicol. 2001;39(12):1225-1232.
Vo TT, Yoo YM, Choi KC, Jeung EB. Potential estrogenic effect(s) of parabens at the prepubertal stage of a postnatal female rat model. Reprod Toxicol. 2010;29(3):306-316.
Sun L, Yu T, Guo J, et al. The estrogenicity of methylparaben and ethylparaben at doses close to the acceptable daily intake in immature Sprague-Dawley rats. Sci Rep. 2016;6:25173.
ECHA c. Substance Information on Butyl 4-hydroxybenzoate. https://www.echa.europa.eu/web/guest/substance-information/-/substanceinfo/100.002.108. Accessed February 08, 2021
Hu C, Nijsten T, van Meel ER, et al. Eczema phenotypes and risk of allergic and respiratory conditions in school age children. Clin Transl Allergy. 2020;10:7.
Scientific Committee on Consumer Safety SO. SCCS (Scientific Committee on Consumer Safety): clarification on Opinion SCCS/1348/10 in the light of the Danish clause of safeguard banning the use of parabens in cosmetic products intended for children under three years of age, 10 October 2011. 2011.
ECHA d. Substance Information on Ethyl 4-hydroxybenzoate. https://www.echa.europa.eu/web/guest/substance-information/-/substanceinfo/100.004.000. Accessed February 08, 2021.
(SCCS) SCoCS. Opinion on Parabens_Updated request for a scientific opinion on propyl- and butylparaben. https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_132.pdf. 2013. Accessed February 08, 2021